Showing results (1671-1680 of 2,636) with videos related to
Sort By:
Pageof 264
Journal of Oncology|October 17, 2022
Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung AdenocarcinomaFeng Xu, Na Xiong, Yuhong Yuan, et al.Journal of Oncology|October 17, 2022
Identification of Gene Coexpression Modules and Prognostic Genes Associated with Papillary Thyroid CancerYanbing Shen, Wenfei He, Dan Wang, et al.Journal of Oncology|October 17, 2022
Immunotherapy Alone or in Combination with Stereotactic Body Radiotherapy in Advanced Lung Cancer: A Pooled Analysis of Randomized Clinical TrialsBi-Cheng Wang, Bo-Hua Kuang, Guo-He LinJournal of Oncology|September 5, 2022
Comprehensive Curative Effect of Targeting PD-1 or Traditional Single-Agent Chemotherapy in Second-Line Therapy for Terminal or Metastatic Esophageal Cancer: A Systematic Review and Meta-AnalysisYidan Wang, Qiuxing Yang, Jia Liu, et al.Journal of Oncology|September 5, 2022
Systematic Analysis of Molecular Subtypes and Immune Prediction Based on CD8 T Cell Pattern Genes Based on Head and Neck CancerLi Yanwei, Feng He, Shuang Liu, et al.Journal of Oncology|September 5, 2022
PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular CarcinomaYifan Lu, Songhai Chen, Qingqing Wang, et al.Journal of Oncology|October 24, 2022
Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10Ning Sun, Chenchen Li, Yue Teng, et al.Journal of Oncology|October 24, 2022
Seven Hub Genes Predict the Prognosis of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA NetworkXueqiong Han, Jianxun Lu, Chun Chen, et al.Journal of Oncology|October 24, 2022
A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic PatientsSaraí G De León Rodríguez, Paúl Hernández Herrera, Cristina Aguilar Flores, et al.Journal of Oncology|October 24, 2022
SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary AdenomaRongxi Huang, Danyan Chen, Hongman Wang, et al.Pageof 264